Stargardt Disease
An inherited retinal disease that causes progressive vision loss, primarily affecting the macula – the central part of the retina responsible for sharp, detailed vision.
Understanding Stargardt Disease
Stargardt Disease is an inherited retinal condition that causes progressive damage to the macula, the central part of the retina responsible for detailed and colour vision. Often developing during childhood, adolescence or early adulthood, it can affect reading, recognising faces, driving and seeing fine detail.
The condition is most commonly caused by changes in the ABCA4 gene, which can lead to the build-up of a fatty waste product called lipofuscin in the retina, damaging retinal cells over time. Also known as Stargardt macular dystrophy or ABCA4-associated retinal disease, its progression varies between individuals, with some experiencing gradual changes and others developing more significant vision loss at a younger age.
Although there is currently no approved cure, advances in genetic testing, retinal imaging and emerging therapies are creating new opportunities for research and management. Retina International works with the global community to advance research, strengthen patient involvement and support progress towards improved outcomes.

1 in 6,500
Estimated prevalence
900+
Disease-associated ABCA4 variants reported
~95%
Of cases associated with ABCA4 (historical estimate)
How Stargardt Disease can affect vision
Blurred or reduced central vision
People may notice difficulty seeing fine details or focusing on objects directly in front of them.
Difficulty reading
Reduced macular function can make reading text, recognising numbers, or viewing screens more challenging.
Difficulty recognising faces
Loss of central vision may affect the ability to identify people or facial details.
Blind spots in central vision
Some individuals develop areas of missing vision in the centre of their visual field.
Colour vision changes
Some people experience reduced colour perception.
Increased sensitivity to bright light
Light sensitivity and difficulty adjusting between bright and dark environments are commonly reported.
Unlike some retinal conditions, peripheral vision is often preserved, particularly in earlier stages.
Identifying Stargardt Disease
Eye examination
An eye care professional (an optometrist or an ophthalmologist) will examine the retina and assess changes associated with Stargardt Disease.
Visual field testing
Visual field testing measures how much of your surroundings you can see while looking straight ahead and helps track changes in your vision over time.
Retinal Imaging
Special scans (Optical coherence tomography) and photographs (fundus photography) of the retina help doctors see changes at the back of the eye.
Electroretinography (ERG)
This test measures how well the cells in your retina respond to light and helps assess retinal function.
Genetic testing
A genetic test can identify the gene change causing Stargardt disease. The results can help explain how the condition is inherited, guide care, and determine whether you may be eligible for research studies or clinical trials.
Current approaches to managing Stargardt Disease
Low vision support
Specialist services can provide:
- Magnification devices
- Assistive technology
- Accessibility tools
- Strategies for adapting daily activities
Vision rehabilitation
Rehabilitation services can support:
- Mobility
- Education
- Employment
- Independent living
Emerging therapies
Research is exploring treatments that aim to:
- Address the underlying genetic cause
- Protect retinal cells
- Slow disease progression
- Restore visual function
Learn more here: https://www.retinalphysician.com/issues/2025/october/novel-therapies-for-stargardt-disease/
Emotional or psychological support
Emotional or psychological support can be of huge benefit in navigating a new diagnosis.
Adapting to changes in central vision
A diagnosis of Stargardt Disease can affect education, employment, independence, and daily activities, particularly because many people are diagnosed during childhood or early adulthood.
People living with Stargardt Disease may benefit from:
- Accessible learning and workplace environments
- Assistive technology
- Low vision rehabilitation
- Peer support
- Patient organisations
- Research participation
Many people with Stargardt Disease continue to pursue education, careers, relationships, and personal goals with appropriate support and adaptations.
The experiences of people living with Stargardt Disease are essential in shaping research priorities and healthcare approaches.

Advancing the future of Stargardt Disease treatment
Gene therapy
Researchers are exploring ways to replace or correct faulty genetic information associated with ABCA4-related disease.
Retinal cell therapies
Retinal cell therapies explore the replacement or regeneration of damaged retinal cells to help restore visual function.
Retinal prostheses and vision restoration technologies
Retinal prostheses and vision restoration technologies use innovative devices and technologies to stimulate remaining retinal pathways and support vision.
Natural history studies and registries
Natural history studies and registries collect long-term data to better understand how disease progresses and to guide future treatment development.
Clinical trials
Clinical studies are investigating potential treatments for people with Stargardt Disease.
Information and community support
Take the Next Step
Stargardt Disease continues to drive innovation in inherited retinal disease research. Through collaboration between patients, researchers, clinicians, and organisations worldwide, progress is being made towards earlier diagnosis, better support, and new treatment possibilities.
-
close